A Moroccan study shows transperineal prostate biopsy delivers similar cancer detection rates to traditional transrectal methods while dramatically reducing infections.
Researchers analyzed 139 men undergoing systematic prostate biopsies. The transperineal approach cut infectious complications from 7.5% to 1.4% - an 80% reduction compared to transrectal procedures.
Both techniques detected clinically significant prostate cancer at comparable rates - 40.3% for transrectal versus 38.9% for transperineal. However, the newer method produced significantly longer core tissue samples, indicating superior sampling quality.
Transperineal biopsies did show slightly higher rates of acute urinary retention at 8.3% versus 6% for transrectal procedures. No severe complications occurred in either group.
The findings support wider adoption of transperineal biopsy as healthcare facilities seek to minimize procedure-related risks while maintaining diagnostic accuracy.